{"product_id":"biolegend-107219","title":"Biolegend, 107219, Brilliant Violet 421™ anti-mouse CD273 (B7-DC, PD-L2) Antibody, 50μg","description":"\u003cp\u003eB7-DC is also called programmed death ligand 2 (PDL2). It has recently been clustered as CD273. This ligand is a 42 kD member of the immunoglobulin receptor superfamily expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. The TY25 antibody has been reported to be useful for blocking PD-1 mediated interactions.\u003cbr\u003e\n50μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: Mouse B7-DC transfected cell line\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450\/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd. Learn more about Brilliant Violet™. This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.\u003cbr\u003e\nExcitation Laser: Violet Laser (405 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1,6, blocking2,4,5 of PD-1 mediated interactions, and immunohistochemistry of acetone-fixed frozen sections3. The Ultra-LEAF™ purified antibody (Endotoxin \u0026lt; 0.01 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107221-107226).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Yamazaki T, et al. 2002. J. Immunol. 169:5538. (FC, IP, WB) Ansari MJI, et al. 2003. J. Exp. Med. 198:63. (Block) Salama AD, et al. 2003. J. Exp. Med. 198:71. (IHC) Matsumoto K, et al. 2004. J. Immunol. 172:2530. (FC, Block) Yamazaki T, et al. 2005. J. Immunol. 175:1586. (Block) Meng Q, et al. 2006. Invest Opthalmol Vis Sci. 47:444. (WB) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Murakami R, et al. 2013. PLoS One. 8:73270. PubMed\u003cbr\u003e\nProduct Citations: Mathew NR, et al. 2021. Cell Reports. 35(12):109286. PubMed Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed Mao C, et al. 2020. Antib Ther. 0.234027778. PubMed Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed\u003cbr\u003e\nRRID: AB_2728127 (BioLegend Cat. No. 107219)\u003cbr\u003e\nStructure: B7 Immunoglobulin superfamily, 42 kD\u003cbr\u003e\nDistribution: Dendritic cells, liver, few transformed cell lines, subset of macrophages; not expressed on lymphoid tissues\u003cbr\u003e\nFunction: Binds to PD-1 and alternative receptor; ligation on DC stimulates, inhibits T cell responses via PD-1 binding, stimulates T cells via alternative receptor binding and promotes tumor immunity\u003cbr\u003e\nLigand\/Receptor: PD-1, uncharacterized receptor\u003cbr\u003e\nCell Type: Dendritic cells, Macrophages\u003cbr\u003e\nBiology Area: Costimulatory Molecules, Immunology\u003cbr\u003e\nMolecular Family: CD Molecules, Immune Checkpoint Receptors\u003cbr\u003e\nAntigen References: 1. Shin T, et al. 2003. J. Exp. Med. 198:31. 2. Liu X, et al. 2003. J. Exp. Med. 197:1721. 3. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29.\u003cbr\u003e\nGene ID: 58205\u003cbr\u003e\nUniProt: View information about CD273 on UniProt.org\u003cbr\u003e\nClone: TY25\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: PD-L2, PDL2, B7DC, CD273\u003cbr\u003e\nIsotype: Rat IgG2a, κ\u003cbr\u003e\nQ: What is the F\/P ratio range of our BV421™ format antibody reagents?\u003cbr\u003e\nA: It is lot-specific. On average it ranges between 2-4.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46864063365289,"sku":"107219","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-107219","provider":"Iright","version":"1.0","type":"link"}